Trials / Completed
CompletedNCT00946790
To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets
Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioavailability of hydroxychloroquine sulfate, 200 mg tablets.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hydroxychloroquine Sulfate Tablets, 200 mg (Geneva Pharmaceutical, Inc.) | |
| DRUG | Hydroxychloroquine Sulfate Tablets, 200 mg, Plaquenil (Sanofi Winthrop) |
Timeline
- Start date
- 1993-07-01
- Primary completion
- 1993-12-01
- Completion
- 1993-12-01
- First posted
- 2009-07-27
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00946790. Inclusion in this directory is not an endorsement.